Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 13, No. 12, 2014, pp. 2015-2020
Bioline Code: pr14278
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 13, No. 12, 2014, pp. 2015-2020
© Copyright 2014 - Tropical Journal of Pharmaceutical Research
Genoprotective and Genotoxic Effects of Thymoquinone on Doxorubicin-Induced Damage in Isolated Human Leukocytes|
Al-Shdefat, Ramadan I.; Abd-ElAziz, Mohamed A. & Al-Saikhan, Fahad I.
Purpose: To investigate the potential genoprotective effects of thymoquinone (TQ) on the cytotoxicity
and genotoxicity-induced by doxorubicin (DXR), a key chemotherapeutic drug.
Methods: Isolated human peripheral leukocytes were treated with varying concentrations of TQ (5.0,
10.0, or 20.0 μM) alone or in combination with DXR (0.15 μg/mL). Comet assays and apoptotic cell
studies were performed to evaluate the effect of TQ on the cytotoxicity and genotoxicity-induced by
Results: TQ treatment, alone, (5.0, 10, or 20 μM) increased DNA damage index (DI) in a concentrationdependent
manner (0.64 ± 0.09, 0.84 ± 0.07, and 0.93 ± 0.06, respectively). DXR (0.15 μg/mL)
increased DI (1.67 ± 0.09) compared with no treatment (0.34 ± 0.03). However, when TQ was
administered with DXR, DI was significantly reduced (0.96 ± 0.04, 0.80 ± 0.05, and 0.79 ± 0.04)
compared with DXR alone (1.67 ± 0.09). Similarly, apoptotic cells decreased (10.8, 11.8 and 14.2 %)
compared with that induced by DXR alone (27.6 %).
Conclusion: TQ can be used as a genoprotective agent against DXR-induced genotoxicity. The dual
behavior of TQ observed in this study is dose-dependent and therefore its mechanism of action needs
to be clarified in future studies.
Thymoquinone; Genotoxicity; Genoprotection; Doxorubicin; Apoptotic; Oxidative stress; DNA damage index
Alternative site location: http://www.tjpr.org